Standard BioTools

SomaLogic, Inc. is a commercial-stage company based in Boulder, Colorado, specializing in protein biomarker discovery and clinical diagnostics. Founded in 1999, the company has developed advanced technologies such as SOMAmers, slow off-rate modified aptamers that specifically bind to target proteins, and the SOMAscan platform, which facilitates comprehensive protein measurement. This innovative approach allows for the analysis of protein biomarker signatures, significantly enhancing the understanding of health and disease beyond traditional genomic methods. SomaLogic's products are utilized in a variety of applications, including diagnostics for conditions in oncology, neurology, and cardiovascular and metabolic diseases, as well as in drug discovery and development. The company also offers diagnostic tests and protein measurement solutions for life science and biopharma researchers, contributing to advancements in medical science.

DVS Sciences, Inc. specializes in manufacturing and distributing advanced bioanalytical solutions aimed at biomarker discovery, biological research, and potential clinical applications. The company is known for its patented multi-parameter system, which includes the CyTOF mass cytometer and a range of MAXPAR reagents featuring stable-isotope-tagged antibodies. This innovative CyTOF-MAXPAR system addresses the limitations of traditional flow cytometry by streamlining sample preparation and enabling the simultaneous identification of up to 100 biomarkers with high resolution and a broad dynamic range. DVS Sciences' CyTOF systems are utilized in leading laboratories across the United States, Canada, and Asia, and support various applications, including multiplex analysis of individual cells, clinical diagnostics, and research into cell populations and gene interactions.